or Try an Advanced Search...

    Clinical Trial Stocks List

    Symbol Grade Name % Change
    OMER B Omeros Corporation 4.39
    SUPN B Supernus Pharmaceuticals, Inc. -0.97
    OPK B OPKO Health Inc. -0.63
    AKRO C Akero Therapeutics, Inc. 0.21
    OCUL C Ocular Therapeutix, Inc. -2.51
    HCM C Hutchison China MediTech Limited -0.78
    CARA D Cara Therapeutics, Inc. 0.33
    GLYC D GlycoMimetics, Inc. -4.61
    BLRX D BioLineRx Ltd. -31.66
    EXAI D Exscientia Limited 0.00
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Drug Discovery Biotechnology Clinical Research Pain Acute Myeloid Leukemia Autoimmune Disease Biopharmaceutical Cataracts Central Nervous System Disease Chemotherapy Clinical Trial Product Hematological Cancers Infectious Diseases Inflammation Medicine Non Small Cell Lung Cancer Nursing Research Pharmaceutical Product Testing Schizophrenia

    Related ETFs - A few ETFs which own one or more of the above listed Clinical Trial stocks.

    Symbol Grade Name Weight
    SURI C Simplify Exchange Traded Funds Simplify Propel Opportunities ETF 6.84
    XPH B SPDR S&P Pharmaceuticals ETF 3.59
    PJP D PowerShares Dynamic Pharmaceuticals 3.47
    PBE D PowerShares Dynamic Biotech & Genome 2.78
    PILL C Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF 2.46
    View all Clinical Trial ETFs...
    Compare ETFs
    Compare SURI to PILL Compare SURI to PJP Compare XPH to PBE

        Clinical Trial Stocks Recent News

        Date Stock Title
        Nov 21 OMER Omeros Corporation Provides Update on Progress Toward BLA Resubmission
        Nov 21 BLRX BioLineRx and Ayrmid Ltd. Enter into Exclusive License Agreement to Commercialize APHEXDA® (motixafortide) through Gamida Cell Ltd.
        Nov 20 OPK OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare Conference
        Nov 20 BLRX BioLineRx to Report Third Quarter 2024 Results on November 25, 2024
        Nov 20 EXAI Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery
        Nov 18 AKRO Akero a new buy at Citi on liver disease asset
        Nov 18 OPK NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition Expo
        Nov 17 CARA Cara Therapeutics Third Quarter 2024 Earnings: Beats Expectations
        Nov 17 OMER Omeros Q3 2024 - Updates On OMIDRIA And Narsoplimab Lead To Liquidity Concerns
        Nov 16 OPK Bitdeer Technologies, PBF Energy, and More Stocks See Action From Activist Investors
        Nov 15 AKRO Akero Therapeutics to Showcase New Analyses of Phase 2b HARMONY Study in Presentations at 75th Annual AASLD The Liver Meeting® 2024
        Nov 15 OCUL Ocular Therapeutix Inc (OCUL) Q3 2024 Earnings Call Highlights: Strong Financial Position and ...
        Nov 15 CARA Cara: Q3 Earnings Snapshot
        Nov 14 OMER Q3 2024 Omeros Corp Earnings Call
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Drug Discovery Biotechnology Clinical Research Pain Acute Myeloid Leukemia Autoimmune Disease Biopharmaceutical Cataracts Central Nervous System Disease Chemotherapy Clinical Trial Product Hematological Cancers Infectious Diseases Inflammation Medicine Non Small Cell Lung Cancer Nursing Research Pharmaceutical Product Testing Schizophrenia
        Clinical Trial

        A clinical trial is a research study in which people volunteer to test new treatments, interventions, or tests as a means to prevent, detect, or treat diseases or conditions. Clinical trials are conducted to determine the safety and effectiveness of new drugs, medical devices, or other treatments.

        Browse All Tags